CD8A and immune system toxicity: Taken together, the results shown in Figs. 2–, 4 demonstrate that tolerance induction to β-gal by AAV gene transfer substantially reduces transgene product-directed immunotoxicity and that the reduction of adenoviral gene transfer-induced liver toxicity and hepatic CD8+ T cell infiltrate is linked to β-gal transgene expression.